Skip to main content

Table 1 Clinical features of NSCLC patients

From: Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma

Items NSCLC patients (N = 381)
Age (years), mean±SD 61.0 ± 10.3
Gender (male/female), No. 286/95
History of smoke, No. (%) 208 (54.6)
History of drink, No. (%) 150 (39.4)
Common complications, No. (%)  
 Hypertension 146 (38.3)
 Hyperlipidemia 120 (31.5)
 Diabetes 62 (16.3)
Differentiation, No. (%)  
 Well 56 (14.7)
 Moderate 228 (59.8)
 Poor 97 (25.5)
Tumor size (cm), mean±SD 5.2 ± 2.1
LYN metastasis, No. (%) 134 (35.2)
TNM stage, No. (%)  
 I 131 (34.4)
 II 107 (28.1)
 III 143 (37.5)
CEA (ng/mL), median (IQR) 6.6 (3.2–27.1)
  1. NSCLC non-small cell lung carcinoma; SD standard deviation; LYN lymph node; CEA carcinoembryonic antigen; IQR interquartile range